Peer Review History
| Original SubmissionMay 5, 2025 |
|---|
|
Dear Dr. Carraro, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please carefully consider the detailed observations provided by the reviewers Please submit your revised manuscript by Sep 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Andrea Martinuzzi Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “This study was funded by the Free University of Bozen-Bolzano, grant No. 6118, as a part of the research project “PE4MOVE - L’educazione Fisica per la promozione dell’attività motoria e sportiva degli studenti nel tempo extrascolastico” [Physical Education to Promote Out-of-School Physical Activity]. The paper publication was also supported by the Open Access Publishing Fund of the Free University of Bozen-Bolzano.” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. 4. In the online submission form you indicate that your data is not available for proprietary reasons and have provided a contact point for accessing this data. Please note that your current contact point is a co-author on this manuscript. According to our Data Policy, the contact point must not be an author on the manuscript and must be an institutional contact, ideally not an individual. Please revise your data statement to a non-author institutional point of contact, such as a data access or ethics committee, and send this to us via return email. Please also include contact information for the third party organization, and please include the full citation of where the data can be found. 5. We note that there is identifying data in Tables 1a and 1b. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws. Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared: -Name, initials, physical address -Ages more specific than whole numbers -Internet protocol (IP) address -Specific dates (birth dates, death dates, examination dates, etc.) -Contact information such as phone number or email address -Location data -ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order) Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants. Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long. Please remove or anonymize all personal information, ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Thank you for the opportunity to review the manuscript PONE-D-25-18111, “The role of physical activity in modulating six-minute walk distance in adolescents”. The article presents original research on the determinants of six-minute walk distance (6MWD) in adolescents. Several issues in clarity, terminology, methodological reporting, and contextualization must be addressed before the manuscript is suitable for publication. My specific comments are organized by manuscript section and line number below. Introduction 1. Lines 47 & 56 - The dichotomy “healthy and clinical populations” is unclear. The term clinical is inappropriate here. Please specify which clinical conditions are being contrasted with healthy cohorts, or replace with more precise language. 2. Line 61 - The phrase “In the last years” is vague. Please specify the time period (e.g. “Between 2015 and 2022, the …”). 3. Lines 54–69 - The categorical grouping of conditions (metabolic, pulmonary, cardiovascular, musculoskeletal) is incorrect (e.g., asthma is pulmonary, not metabolic or musculoskeletal). Revise or clarify to ensure each condition is referred to or classified correctly. 4. Lines 72–74 - Change “Most considered variables” to “Variables with the greatest predictive weight” (or similar). 5. Lines 88–89 - Revise “different contexts” to “different geographic or demographic contexts,” since variation may occur within a single country. 6. Lines 88–96 - The terms “reference values,” “equations,” and “population standards” are used without sufficient contextualisation. Be more specific when referring to these factors – (e.g equations for what? population standards for what?). Explain what outcomes the equations predict, and cite recent literature justifying the need for improved 6MWD prediction models. 7. Lines 95–98 - The assertion that “better results were reported in middle-income countries” lacks substantiation. Provide references, acknowledge the absence of socioeconomic data in prior studies, and offer plausible explanations for observed differences. 8. Lines 99–117 - The rationale for conducting this study in Italy is underdeveloped in this section. Please review relevant European or Italian adolescent health literature to establish the study’s necessity and contextualize the findings. Furthermore, while the authors acknowledge the link between cardiovascular health and 6MWD – there is little rationale explaining why these two are relevant to the population understudy. Methods Measures • Line 139 - Define “CRF” (cardiorespiratory fitness) at first mention. Statistical Analyses 1. Line 166 - Excluding participants without complete personal data may introduce selection bias. Acknowledge this in the limitations. 2. Line 169 - A non-normal distribution was noted, yet results are summarized using means and standard deviations. Report medians and interquartile ranges instead, or justify why mean ± SD are appropriate. 3. Lines 169–180 - The use of a linear regression analysis appears unsubstantiated and requires elaboration. Given the non-normal distribution. the data is likely to violate several assumptions that are essential to consider when conducting a linear regression. Specify which regression assumptions were tested (e.g., normality of residuals, homoscedasticity), present these diagnostics in a supplement, and cite best practices for outlier removal and model selection criteria (AIC/BIC). It remains unclear whether all predictors were entered into a single regression model. Including highly correlated variables (height, weight, and BMI) violates the independence assumption, introduces multicollinearity, inflates standard errors, and undermines interpretability. If BMI is included alongside height and weight, the model essentially attempts to partition shared variance among highly correlated predictors, violating the assumption of independence among predictors and potentially leading to misleading conclusions. I strongly recommend revisiting the model either (a) modelling BMI alone or (b) modelling height and weight separately with age to determine interactions. Results 1. Line 188 - Clarify whether the reported BMI (“20.00 ± 3.20 kg/m²”) is mean ± SD or median (IQR). Could the authors include more information on BMI and how it reflects overall health status in this context? As it stands, it is difficult to assess whether the individuals in the study can be considered healthy, especially given the lack of clinical or physiological markers beyond BMI. Clarifying this would help readers better understand the health profile of the study population – and provide context to the utility of MVPA as a marker of CRF. 2. Line 190 - The statement regarding WHO-recommended MVPA levels belongs in the Discussion. 3. Line 190 - Justify the exclusion of outliers by age group and provide details in a supplement. 4. Line 201 - When reporting sex differences in 6MWD, specify whether these differences apply across all ages or vary by age subgroup. 5. Line 214 - Clarify whether “6MWT” differs from “6MWD” or if the terms are used interchangeably. 6. Figure 1a & 1b - Add individual data points or provide supplementary scatterplots to allow readers to assess distribution and potential clustering. Discussion 1. Lines 223–240 – The authors need to re-evaluate their models, and ensure their discussion addresses possible interaction effects. 2. Lines 250–251 - When comparing your results to those from Acuri et al. (2016) and other countries, discuss potential cultural, socioeconomic, or environmental factors that may account for observed similarities or differences between Italian adolescents and peers in Switzerland, Tunisia, Austria, and Brazil. 3. Line 273 - The phrase “state of physical fitness” is vague. Specify whether you refer to objectively measured fitness, self-reported activity levels, or other proxies, and discuss potential biases or population differences. 4. Line 274 & 283–285 - Define “PA” (physical activity) when first used. Consider interactions between MVPA and BMI in your models - does BMI moderate the effect of MVPA on 6MWD? Also discuss how gendered social norms, environmental opportunities, and motivational factors might influence activity levels. 5. Interpretation of Correlations - The positive correlations of age, height, and BMI with 6MWD in males (versus negative in females) warrant deeper biological, social, and cultural contextualization in light of adolescent growth trajectories and gender norms relating to health and fitness. 6. MPVA Findings - Discuss why MVPA levels fell below WHO recommendations despite the study population being a seemingly healthy cohort. 7. Adolescent 6MWD Decline - Explore literature addressing the decline in 6MWD between ages 13–16, linking to pubertal development, motivational factors, or methodological considerations. Limitations • Several limitations are not addressed, including selection bias from data exclusions, potential measurement error in MVPA assessment, and the generalizability of findings beyond a high-income, European context. • Furthermore, while the authors mention some limitations they do not elaborate on how these may have influenced the study’s design or findings. Conclusion The manuscript addresses a valuable research question, but substantial revisions are needed to clarify terminology, strengthen methodological transparency, ensure statistical validity, and properly contextualize. I would be happy to review a revised version of the manuscript that addresses these concerns. Reviewer #2: Authors covered a gap in the literature related to the normative data in Italian adolescents about 6MWT. The sample is big and representative of the agegroup. However it has been colleceted only in one region as mentioned as limitation by the authors. I have some doubt about the self report measure. Authgors should spend some more words in the discussion about the limitation of the study, since it has been reported in the cited paper (Booth; the physical activity questions in the WHO health behaviour in schoolchildren (HBSC) survey) that there is an agrement from 70% to 85% in test retest. Moreover some references about the reliability with objective measure should be reported. Also self reporting heigth and weigth could introduce biases. In table 2 it is not reported the regression for age in males. Please add. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Elizabeth S. Dinkele Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Dear Dr. Carraro, Please submit your revised manuscript by Mar 15 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Andrea Martinuzzi Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Please take care of the last 3 minor changes requested by the reviewer 1 [Note: HTML markup is below. Please do not edit.] Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: I would like to commend the authors of this manuscript, and on their efforts to answer and address all the questions from my review. There are three small comments that I would like to see addressed, and then I would be more than happy to recommend this for publication: 1. Line 186: The authors reference a "robust standard errors method". Please include a reference for this. 2. Line 199: Revise the wording 'highest percentage of people (26.7%)' - this amount cannot be the highest percentage of people, and should be worded differently. 3. Inclusion of some of the research cited in the authors responses: 3a. In response to my comment regarding specifying whether sex differences occur by age the authors provide rich context as to the possible biological sex-related differences and this would enrich the introduction/discussion if included. Specifically, "Speaking generally, differences between males and females in youth are very common, especially in terms of cardiorespiratory fitness (doi:10.1161/CIR.0000000000000866, doi: 10.5604/01.3001.0053.7363, doi: 0.3389/fped.2021.657551). Potential explanations for this difference include sex-related differences in muscle fibre type, oxygen extraction, or the lipid content of myofibrils (doi: 10.1016/j.jsams.2008.05.006, doi: 10.1152/ajpregu.00472.2006)." 3b. In response to my comment :'Discuss why MVPA levels fell below WHO recommendations despite the study population being a seemingly healthy cohort". The authors state: "As a result, the absence of immediate, visible outcomes can lead to a lack of motivation to engage in physical activity during leisure time. Additionally, urban environments often lack accessible and safe spaces for outdoor activities, further limiting opportunities for movement. The widespread use of smartphones, streaming platforms, and video games has also contributed to an increasingly sedentary lifestyle among adolescents. Moreover, shifting priorities toward academic responsibilities, social interactions, and digital engagement may lead to physical activity being deprioritized in daily routines of adolescents. While these variables may hold relevance, they were not investigated as part of the present. While these variables may hold relevance, they were not investigated as part of the present study. Therefore, we could not discuss these factors in detail". I believe the findings in your article would be enriched by including the context provided in your response to my comment. I would once again like to commend the authors for the quality of this research and for being open taking the suggested revisions. I look forward to reading this article in press! Reviewer #2: Authors have adressed my comments. I do not have any other comment and suggest acceptance of the manuscript ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Elizabeth S. Dinkele Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
The role of physical activity in modulating six-minute walk distance in adolescents PONE-D-25-18111R2 Dear Dr. Carraro, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Andrea Martinuzzi Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-18111R2 PLOS One Dear Dr. Carraro, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Andrea Martinuzzi Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .